GRIN2A and Anxiety: Our principal findings indicate that MN pre‐treatment attenuates seizure severity, prevents PTZ‐induced upregulation of the GluN2A NMDA receptor subunit, mitigates oxidative stress markers, and normalizes anxiety‐like behaviors measured 24 h post‐seizure.